Agilent Technologies (A) Cash & Equivalents (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash & Equivalents of $1.8 billion for Q2 2026, up 21.6% year-over-year from $1.5 billion in Q2 2025, and up 2.79% quarter-over-quarter from $1.8 billion in Q1 2026.
Agilent Technologies (A) Cash & Equivalents (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Cash & Equivalents for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Equivalents rose 21.6% year-over-year to $1.8 billion; the TTM figure through Apr 2026 stood at $1.8 billion (up 21.6% YoY), while the FY2025 annual figure was $1.8 billion, up 34.61% from the prior year.
- Cash & Equivalents advanced to $1.8 billion in Q2 2026 per A's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $1.8 billion in Q2 2026 and bottomed at $1.1 billion in Q4 2022.
- Historically, Cash & Equivalents has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2025.
- Annual changes were most pronounced in 2022 — Cash & Equivalents declined 29.04% — and 2023, when it jumped 51.0%.
- Agilent Technologies' Cash & Equivalents stood at $1.1 billion in 2022, then soared by 51.0% to $1.6 billion in 2023, then declined by 16.42% to $1.3 billion in 2024, then surged by 34.61% to $1.8 billion in 2025, then climbed by 1.01% to $1.8 billion in 2026.
- Business Quant data shows A's Cash & Equivalents at $1.8 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.8 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.10 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 1.91 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 196.93 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.04 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 141.80 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 626.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.81 Bn |
| Jan 31, 2026 | 1.76 Bn |
| Oct 31, 2025 | 1.79 Bn |
| Jul 31, 2025 | 1.54 Bn |
| Apr 30, 2025 | 1.49 Bn |
| Jan 31, 2025 | 1.47 Bn |
| Oct 31, 2024 | 1.33 Bn |
| Jul 31, 2024 | 1.78 Bn |
| Apr 30, 2024 | 1.67 Bn |
| Jan 31, 2024 | 1.75 Bn |
| Oct 31, 2023 | 1.59 Bn |
| Jul 31, 2023 | 1.33 Bn |
| Apr 30, 2023 | 1.18 Bn |
| Jan 31, 2023 | 1.25 Bn |
| Oct 31, 2022 | 1.05 Bn |
| Jul 31, 2022 | 1.07 Bn |
| Apr 30, 2022 | 1.19 Bn |
| Jan 31, 2022 | 1.11 Bn |
| Oct 31, 2021 | 1.48 Bn |
| Jul 31, 2021 | 1.43 Bn |